Frauke Hein
Chief Executive Officer at SCIENION- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
SCIENION
-
Germany
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Executive Officer
-
Jun 2022 - Present
Germany
-
-
-
InfectoGnostics Research Campus Jena
-
Germany
-
Research Services
-
1 - 100 Employee
-
Advisory Board Member
-
Apr 2021 - Present
Jena, Thuringia, Germany
-
-
-
Innovationspreis Berlin Brandenburg
-
Germany
-
Newspaper Publishing
-
Jury Member Healthcare, Berlin Brandenburg Region Innovation Award
-
Jun 2019 - Present
Berlin, Germany
-
-
-
-
Board Member
-
Mar 2015 - Present
Jena, Thuringia, Germany
-
-
-
NLC Health Ventures
-
Netherlands
-
Hospitals and Health Care
-
1 - 100 Employee
-
Venture Advisor
-
Jan 2021 - Jul 2022
Amsterdam, The Netherlands
-
-
-
Adrenomed AG
-
Germany
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chief Business Officer and cofounder
-
Sep 2011 - Jun 2022
Hennigsdorf, bei Berlin Heading and executing all strategic, marketing and business development / licensing activities leading to the vision to become a leader in targeting vascular integrity for treating life threatening diseases. In charge of for biopharma partnering and alliance management, IR and corporate communication strategy. In that position I am overseeing company business planning and execution, defining the company and product positioning and strategic R&D direction. Succesfully fundraising of >60 Mio€ .
-
-
-
-
Director Portfolio Management
-
Sep 2011 - Sep 2017
Berlin
-
-
-
Thermo Fisher Scientific
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Director Project Coordination R&D
-
Oct 2009 - Aug 2011
Hennigsdorf Chross-functional leadeship role. In charge of R&D controlling. Leading the project team for the launch of B·R·A·H·M·S Copeptin proAVP KRYPTOR, an automated test for early rule out of myocardial infarction. Initiation and securing the funding of a telemedicine project (FONTANE) for validation of the biomarker adrenomedullin as short term risk monitoring tool in heart failure outpatients (“Point ofCare@Home”).
-
-
-
BRAHMS AG Pharmazeutische Diagnostika
-
Germany
-
Medical Equipment Manufacturing
-
1 - 100 Employee
-
Director Research & Development
-
Sep 2007 - Sep 2009
Hennigsdorf, Germany Chross functional project coordination of R&D Department. Responsible for financial and strategic planning, budgeting and coordination of global R&D projects in the field of biomarkers in cardiology, liver disease, sepsis and neurodegeneration. Initiation and assessment of new disease areas. KOL Management.
-
-
-
Economic Development Agency Brandenburg (WFBB)
-
Germany
-
Business Consulting and Services
-
1 - 100 Employee
-
Director Life Science
-
Jan 2001 - Aug 2007
Potsdam Area, Germany ZAB Brandenburg Economic Development Board Building up and leading a team responsible for assessment and managing of research and product development grants of life science companies in Brandenburg. Advising financing and strategic planning for innovative bio-/medtec start-ups. Technology and market assessment for Venture Capital.
-
-
-
-
Project Manager Biotechnology
-
Apr 2000 - Dec 2000
Potsdam Area, Germany Merged with WfBB to ZAB Bandendurg Economic Development Board Technology and market assessment of Biotech / Mectech R&D Projects of Companies in the state of Brandenburg
-
-
Education
-
University of Münster
Doctor of Philosophy - PhD, Biotechnology and Biochemistry of Plants -
University of Münster
Diploma in Biology